Cases 31 - 40 of 270
Marlene Boyadjian v. GlaxoSmithKline, LLC et al
as 2:2021cv09378
Plaintiff:
Marlene Boyadjian
Defendant:
GlaxoSmithKline, LLC, Boehringer Ingelheim Pharmaceuticals, Inc., Sanofi US Services Inc. and others
Cause Of Action: 28 U.S.C. § 1441
Smith v. GlaxoSmithKline, PLC et al
as 4:2021cv09390
Plaintiff:
Jasmine Smith
Defendant:
GlaxoSmithKline, PLC and GlaxoSmithKline Consumer Healthcare
Cause Of Action: 28 U.S.C. § 1332
Hartman v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
as 1:2021cv00428
Plaintiff:
Ruth Hartman
Defendant:
Boehringer Ingelheim Pharmaceuticals, Inc., BOEHRINGER INGELHEIM USA CORPORATION, BOEHRINGER INGELHEIM INTERNATIONAL GMBH and others
Cause Of Action: 28 U.S.C. § 1332
Husrom et al v. Las Vegas Medical Group, LLC et al
as 2:2021cv01929
Plaintiff:
Yasmin Husrom and Jamil Husrom
Defendant:
Las Vegas Medical Group, LLC, Nauman Jahangir, M.D., GlaxoSmithKline, LLC and others
Cause Of Action: 28 U.S.C. § 1441
Charlene Simmons v. GlaxoSmithKline, LLC et al
as 2:2021cv06465
Plaintiff:
Charlene Simmons
Defendant:
GlaxoSmithKline, LLC, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation and others
Cause Of Action: 28 U.S.C. § 1441
Wendy Van Dalm et al v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
as 2:2021cv05920
Plaintiff:
Wendy Van Dalm and Mark Van Dalm
Defendant:
Walmart Inc., Boehringer Ingelheim Pharmaceuticals Inc, Sanofi US Services, Inc. and others
Cause Of Action: 28 U.S.C. § 1441
Audra Galang v. Sanofi S.A. et al
as 2:2021cv04869
Defendant:
Pfizer Inc.,, CHATTEM INC., Sanofi S.A. and others
Plaintiff:
Audra Galang
Cause Of Action: 28 U.S.C. § 1446 pl
Robin Mizrahi v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
as 2:2021cv04111
Defendant:
Chattem, Inc., Amneal Pharmaceuticals, LLC, CVS Pharmacy, Inc and others
Plaintiff:
Robin Mizrahi
Cause Of Action: 28 U.S.C. § 1332
Plaintiff v. Defendant
as 9:2021cv00056
Defendant:
Plaintiff v. Defendant
Plaintiff:
Plaintiff v. Defendant
Cause Of Action: 42 U.S.C. § 12102
Marina Golden v. Sanofi-Aventis U.S., LLC et al
as 2:2021cv03793
Defendant:
Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals, Inc., Taro Pharmaceuticals U.S.A., Inc. and others
Plaintiff:
Marina Golden
Cause Of Action: 28 U.S.C. § 1441
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
